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Biotechnology is sweeping U.S. agriculture. Like earlier
technological advances, biotech promises new gains in produc-
tivity—but also offers much more. The new wave of biotech
could give farmers more control over their products’ attrib-
utes, enabling producers to tailor farm products for specific
consumer needs.
Biotech also promises to help redraw the rural landscape,
adding to the momentum toward fewer and larger farms and
encouraging the recent shift toward product supply chains.
While biotech could give a needed boost to rural communities
that become processing centers for high-value, biotech prod-
ucts, it will also underscore the challenges facing producers and
communities that stay tied to commodities.
The future of biotech rests on consumer acceptance. Some
consumers are skeptical and believe that the environment and
food safety may be at risk. Unless this hurdle of acceptance is
cleared, biotech’s promise of a bold new future could be at risk.
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Biotech’s New Wave
Biotechnology refers to the manipula-
tion of the genetic code to create new and
useful products. Now that the entire
human genetic code has been deciphered,
biotech terms like gene splicing and
genetic engineering are becoming house-
hold words. It could be only a matter of
time before biotech food products become
just as widespread. 
Biotech certainly isn’t new to U.S.
agriculture. The initial wave of biotech
products in the industry focused primarily
on improving farming methods and tech-
niques. Striking examples are crop varieties
engineered to be tolerant to widely used
herbicides, helping farmers eliminate
weeds from their fields without harming
crops. Other crop varieties have been bio-
engineered to resist common insect pests.
A new wave of biotech products will
soon emerge from the nation’s laborato-
ries. In contrast to the first biotech wave,
which focused on improving farming
techniques, the new wave of biotech
focuses on adding or improving product
attributes for consumers. For example,
peppers will grow with a firmer texture,
tomatoes will live longer on the shelf, and
potatoes will resist bruising.
More exotic examples of second-wave
biotech products are “nutriceuticals,” a new
class of farm products that enhance nutri-
tion or even produce medicinal benefits. An
early nutriceutical is “golden rice,” engi-
neered to include genes from bacteria and
daffodils. The result is an elevated level of
beta-carotene, which is converted to
vitamin A when consumed. Scientists hope
the new vitamin-fortified rice will be grown
in third-world nations where rice is the
dietary staple of many of the world’s
poorest people. Scientists are also engineer-
ing varieties of bananas and other third-
world crops so that they will offer resistance
to hepatitis and other common diseases.
Can Biotech Change
Rural America?
Advances in biotechnology promise to
leave an indelible mark on U.S. agriculture
and the rural communities that rely on it.
The eventual effects of biotech on farms
and rural communities across America,
however, could differ substantially.
Farmers were quick to capitalize on
the first-generation of biotechnology. Since
the commercial launch of herbicide-toler-
ant or insect-resistant crops in 1996, the
share of U.S. crops planted to biotech has
soared to about a fourth for corn and well
over half for soybeans and cotton. This
rapid adoption of biotech by farmers is
not surprising in light of agriculture’s long
record of adopting the most recent tech-
nology to save time and boost crop yields.
The time required to produce 100 bushels
of corn, the nation’s largest crop, has
plunged from more than 80 hours a
century and a half ago to only about two
hours today (Chart 1). 
Like previous technological advances,




















down from about 6 million farms a half
century ago to about 2 million today. The
nation’s largest 200,000 farms account for
roughly two-thirds of total U.S. output of
food and fiber.
With the new wave of biotechnology
catching on, however, we are likely to see a
new twist in the industry’s long-standing
migration toward fewer and bigger busi-
nesses. Unlike most previous farm tech-
nologies, the second biotech wave is focus-
ing on the attributes of farm products
rather than on how products are produced.
In essence, biotech is now letting farmers
tailor their products for specific consumer
niches, transforming agriculture from a
commodity business to a product business.
The industry’s new product focus is
likely to encourage the development of
product supply chains, which has
advanced rapidly in recent years. Supply
chains are carefully orchestrated produc-
tion, processing, and marketing channels
that stretch from farms to supermarkets.
At each step along the chain, contract
specifications ensure buyers that new
biotech products meet intended specifica-
tions, to keep new bio-engineered farm
products on target for their intended
market niches. 
How agriculture’s emerging supply-
chain structure will affect producers and
rural communities remains an issue of
considerable debate (and an important
focal point for research in the Center for
the Study of Rural America). For produc-
ers, the new technology is sharpening the
choice between a business plan focused on
commodities and one focused on prod-
ucts. Commodity producers face volatile
prices, razor-thin margins, and a relentless
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who join supply chains lose some manage-
ment flexibility, but many producers would
gladly trade this flexibility to share market
risks and larger prospective margins with
other chain members.
It is also likely that supply chains will
create a new pattern of growth and decline
among rural communities. The long-stand-
ing trend of farm consolidation and a corre-
sponding drop in the number of farm
families doing business locally has weak-
ened many farm-dependent rural commu-
nities. Moreover, big farms are more likely
to bypass local markets when purchasing
production inputs and selling farm prod-
ucts. In contrast, supply chains may provide
a boost to some rural communities, as addi-
tional local processing activity enables them
to gain from the value biotechnology adds
to farm products. Still, these new hubs of
value-added activity may be relatively few
and far between, resulting in a patchwork
of rural growth rather than a fundamental
groundswell.
Will Consumers Accept Biotech?
While the initial adoption of biotechnol-
ogy by farmers has been quick and its
promise appears huge, biotech’s future
remains uncertain. The key issue clouding
prospects for further advances is consumer
acceptance. During the past year, some con-
sumers have expressed deep skepticism of
biotechnology. Unless consumers are con-
vinced biotech is safe, its promise will be lost.
Despite the claims of the scientific
community to the contrary, some con-
sumers perceive two important risks from
biotechnology. The first is an environmen-
tal risk, stemming from the fear the new
technology will encourage the evolution of
especially hardy or harmful “super” weeds
or insect pests, or that friendly insects—
like the monarch butterfly—might be hurt
when feeding on biotech crops.
The second perceived risk of biotech
involves food safety. Some consumers fear
that foods or food ingredients made from
biotech crops might eventually prove
unhealthy—so-called “Frankenfoods.”
Whether real or imagined, consumer per-
ceptions of both of these risks have become
part of the market reality facing farmers,
agricultural businesses, and food companies
that wish to use the new technology.
Consumer perceptions of biotech risks
appear to differ widely around the globe.
U.S. consumers have been relatively accept-
ing of the technology. That acceptance is
probably built on a fundamental confidence
in science and the well-developed apparatus
that monitors it. The U.S. Department of
Agriculture oversees field-testing and
ensures that new crop varieties improved
through biotechnology are at least as safe as
those developed through traditional breed-
ing programs. The Environmental
Protection Agency ensures the safety of
crops with pest protection characteristics.
And the Food and Drug Administration
guards the safety of all foods and ingredi-
ents developed with biotechnology or by
other means.
In contrast, consumers in some inter-
national markets for U.S. farm products—
especially the European Union—are
considerably more skeptical. Underlying
that skepticism might be recent food-safety
scares, such as the outbreak of mad-cow
disease in England, which have eroded con-
fidence in food safety and its regulation.
Biotech proponents are searching for
ways to gain consumer acceptance. One
alternative is to segregate and label biotech
and non-biotech products, offering discrim-
inating consumers a choice. Segregating
biotech and non-biotech commodities is a
logistical challenge, though, that boosts
costs throughout the marketing pipeline.
And since first-generation biotech products
offer no additional value over non-biotech
products, consumers are unwilling to pay
higher food prices to cover the added costs
of pipeline segregation. Thus, a key eco-
nomic trade-off is emerging as the industry
weighs the additional costs of segregation
against the productivity gains made possible
by first-generation biotechnology.
Labeling food products that contain
biotech ingredients also presents a quandary
for food companies. Many food companies
are concerned that consumers will view a
label indicating the use of biotechnology as
a warning rather than a simple menu of
ingredients. Thus, several food companies
have already elected to exclude biotech
ingredients from their product lines. If such
exclusion becomes widespread, further
development and deployment of biotech
products could be brought to a halt. That is
generally the situation in Europe, where
consumers remain deeply skeptical.
The new wave of biotech products may
help resolve the consumer acceptance issue.
New biotech products like nutriceuticals
provide enhanced benefits directly to con-
sumers. As those new products are devel-
oped and come to market, consumers will
be able to weigh a growing menu of product
benefits against the perceived environmental
and food safety risks. Eventually, the balance
of rewards and perceived risks may tip in
favor of consumer acceptance.
Conclusions
Biotech promises sweeping changes for
farmers, rural communities, and consumers.
For farmers, biotech promises further gains
in productivity, far more control over
product attributes and quality, and a stark
choice between commodity and product
businesses. For rural communities, the tech-
nology promises a new patchwork of
growth and decline, as some communities
become processing hubs for agriculture’s
new biotech products. For consumers,
biotechnology promises an array of new
and improved food products, with quality,
nutritional, and even medicinal benefits
hardly imaginable a few years ago. All of
these promises, however, hang in the
balance of consumer acceptance. Unless
consumers perceive a more favorable
balance of risks and rewards, biotech’s
bright promise could be denied.
Nancy Novack, a research associate in the Center,
helped prepare this article.
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Survey of Agricultural Credit Conditions
Federal Reserve Bank of Kansas City
June 30, 2000
Highlights from the second quarter survey.
• After two quarters of strong gains, district farmland values held steady in the second quarter of 2000. Dry conditions in Missouri,
Oklahoma, and western Nebraska put downward pressure on cropland values, but values remain modestly above year-ago levels.
District ranchland values, on the other hand, rose 1.2 percent in the quarter and remain well above year-ago levels. Favorable
conditions in the livestock sector have combined with nonfarm influences such as urban sprawl, scenic amenities, and recreational
activities to lift district ranchland values in recent quarters. 
• The district farm commodity price index rose 1.1 percent in the second quarter to a level 12.9 percent above the previous year.
Drought conditions lifted wheat and soybean prices in the district, while hog and cattle prices continued to climb. Since the
second quarter, however, improved weather conditions and forecasts of another large fall harvest have dampened crop prices.
Strong consumer demand for meat has supported cattle and hog prices, despite a steady flow of livestock to market this year.
• The demand for farm loans remained healthy in the quarter, but repayment rates edged down and loan renewals or extensions were
flat. The loan-to-deposit ratio continued to climb with more respondents indicating their ratio was above desired levels. Bankers
remain concerned about producer’s ability to repay loans without government aid, the source of nearly half of U.S. net farm
income this year.
• Rising interest rates have been another concern for district bankers and producers. At the end of the second quarter, average inter-
est rates on new farm loans were 41 basis points higher than the quarter before. Interest rates on new farm loans averaged 10.52
percent for operating loans, 10.35 percent for feeder cattle loans, 10.31 percent for intermediate-term loans, and 10.06 percent for
real estate loans. 
Note: 287 bankers responded to the second quarter survey.
Kendall McDaniel, associate economist with the Center, can respond to questions at 816-881-2291, or kendall.l.mcdaniel@kc.frb.org.
Farm Real Estate Values
June 30, 2000
(Average value per acre by reporting banks)
Nonirrigated Irrigated Ranchland
Kansas $641 $1,025 $372
Missouri 911 1,078 624
Nebraska 856 1,436 355
Oklahoma 504 738 348
Mountain states* 333 1,130 217
Tenth District $671 $1,165 $368
Percent change from:
Last quarter+ 0.97 0.32 1.16
Year ago+ 2.45 1.72 7.07
Market high -20.45 -19.07 -9.48
Market low 69.55 71.38 120.07 
* Colorado, New Mexico, and Wyoming combined.
+ Percentage changes are calculated using responses only from
those banks reporting in both the past and the current quarter.
Source: Federal Reserve Bank of Kansas City
Selected Measures of Credit Conditions
at Tenth District Agricultural Banks
Loan Loan Average Loan-to- District
Loan Fund repayment renewals or deposit farm commodity
demand availability rates extensions ratio* price index
(index)+ (index)+ (index)+ (index)+ (percent) (1980=100)
1998
Jan.-Mar. 120 108 93 109 65.9 94.3
Apr.-June 123 100 78 118 68.0 92.2
July-Sept. 112 99 58 136 68.4 78.7
Oct.-Dec. 107 108 55 138 66.9 80.7
1999
Jan.-Mar. 105 113 56 143 65.7 86.0
Apr.-June 107 107 71 127 66.5 87.8
July-Sept. 103 90 74 126 67.7 87.0
Oct.-Dec. 100 99 86 115 67.7 91.2
2000
Jan.-Mar. 107 95 92 108 67.1 97.9
Apr.-June 112 78 86 108 70.4 99.1
* At end of period.
+ Bankers responded to each item by indicating whether conditions during the current quarter
were higher than, lower than, or the same as in the year-earlier period. The index numbers
are computed by subtracting the percent of bankers that responded “lower” from the
percent that responded “higher” and adding 100.
Source: Federal Reserve Bank of Kansas City
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